4.8 Article

Computational modelling suggests that Barrett's oesophagus may be the precursor of all oesophageal adenocarcinomas

期刊

GUT
卷 70, 期 8, 页码 1435-1440

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/gutjnl-2020-321598

关键词

Barrett's oesophagus; Barrett's carcinoma; oesophageal cancer; screening; pre-malignancy; gi tract

资金

  1. NIH grants [CISNET U01 CA152926, U01 CA199336, K24 DK080941]
  2. UKRI Rutherford Fund Fellowship
  3. NIH [U54 CA163059, U54 CA163060, P50 CA150964]
  4. MRC [MR/S003851/1] Funding Source: UKRI

向作者/读者索取更多资源

The study aimed to determine whether Barrett's esophagus is the origin of all incident esophageal adenocarcinomas, and found that almost all cases of OAC could be attributed to Barrett's esophagus based on a computational model and population data.
Objective Barrett's oesophagus (BE) is a known precursor to oesophageal adenocarcinoma (OAC) but current clinical data have not been consolidated to address whether BE is the origin of all incident OAC, which would reinforce evidence for BE screening efforts. We aimed to answer whether all expected prevalent BE, diagnosed and undiagnosed, could account for all incident OACs in the US cancer registry data. Design We used a multiscale computational model of OAC that includes the evolutionary process from normal oesophagus through BE in individuals from the US population. The model was previously calibrated to fit Surveillance, Epidemiology and End Results cancer incidence curves. Here, we also utilised age-specific and sex-specific US census data for numbers at-risk. The primary outcome for model validation was the expected number of OAC cases for a given calendar year. Secondary outcomes included the comparisons of resulting model-predicted prevalence of BE and BE-to-OAC progression to the observed prevalence and progression rates. Results The model estimated the total number of OAC cases from BE in 2010 was 9970 (95% CI: 9140 to 11 980), which recapitulates nearly all OAC cases from population data. The model simultaneously predicted 8%-9% BE prevalence in high-risk males age 45-55, and 0.1%-0.2% non-dysplastic BE-to-OAC annual progression in males, consistent with clinical studies. Conclusion There are likely few additional OAC cases arising in the US population outside those expected from individuals with BE. Effective screening of high-risk patients could capture the majority of population destined for OAC progression and potentially decrease mortality through early detection and curative removal of small (pre)cancers during surveillance.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据